Course Provider
Learning Objectives
Participants will integrate recent advances and available clinical data to optimally select and sequence agents based on HR/HER2-status and biomarkers.
Participants will discuss new therapies available for metastatic breast cancer.
Participants will describe common issues faced by survivors living with metastatic breast cancer.